Antibacterial agents agent in preclinical development
This is the World Health Organization’s first comprehensive overview of the preclinical antibacterial pipeline to date based on publicly available data on each included project. This report and the respective WHO database capture 252 antibacterial agents in development targeting the pathogens on the WHO priority pathogens list, Mycobacterium tuberculosis and Clostridioides difficile. The preclinical pipeline is dynamic and scientifically diverse, with agents being developed in many parts of the world to prevent and treat drug-resistant bacterial infections.
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!